Kristine Nishida

Kristine Nishida

Auto-generated profile, based on publicly available information

Kristine Nishida

Johns Hopkins School of Medicine, Johns Hopkins University 2 Department of Pulmonary and Critical Care Medicine Baltimore, Maryland, 21224 , USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2022 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
BGBaishakhi Ghosh
Baishakhi Ghosh
KNKristine Nishida
Kristine Nishida
LCLakshmana Chandrala
Lakshmana Chandrala
SMSaborny Mahmud
Saborny Mahmud
STShreeti Thapa
Shreeti Thapa
VSVenkataramana K. Sidhaye
Venkataramana K. Sidhaye
The airway epithelium is subjected to insults such as cigarette smoke (CS), a primary cause of chronic obstructive pulmonary disease (COPD) and serves as an excellent model to study cell plasticity. Here, we show that both CS-exposed and COPD-patient derived epithelia (CHBE) display quantitative evidence of cellular plasticity, with loss of specialized apical features and a transcriptional profile suggestive of partial epithelial-to-mesenchymal transition (pEMT), albeit with distinct cell motion indicative of cellular unjamming. These injured/diseased cells have an increased fraction of polymerized actin, due to loss of the actin-severing protein cofilin-1. We observed that decreasing polymerized actin restores the jammed state in both CHBE and CS-exposed epithelia, indicating that the fraction of polymerized actin is critical in unjamming the epithelia. Our kinetic energy spectral analysis suggests that loss of cofilin-1 results in unjamming, similar to that seen with both CS exposure and in CHBE cells. The findings suggest that in response to chronic injury, although epithelial cells display evidence of pEMT, their movement is more consistent with cellular unjamming. Inhibitors of actin polymerization rectify the unjamming features of the monolayer. This article has an associated First Person interview with the first author of the paper.

1 April 2021 in Cancer Letters
Verified
Journal Article
Closed access
KKKimberley Katleba
Kimberley Katleba
ALAlan P. Lombard
Alan P. Lombard
MTMaria Malvina Tsamouri
Maria Malvina Tsamouri
HBHan Bit Baek
Han Bit Baek
KNKristine S. Nishida
Kristine S. Nishida
Maria MudryjMaria Mudryj
Maria Mudryj

1 May 2020
Verified
Conference Paper
Open access
BGB. Ghosh
B. Ghosh
JLJ. Loube
J. Loube
SCS. Chen
S. Chen
KNK. Nishida
K. Nishida
LYL. Ying
L. Ying
VSV.K. Sidhaye
V.K. Sidhaye

15 February 2022 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
BGBaishakhi Ghosh
Baishakhi Ghosh
KNKristine Nishida
Kristine Nishida
First Person is a series of interviews with the first authors of a selection of papers published in Journal of Cell Science, helping early-career researchers promote themselves alongside their papers. Baishakhi Ghosh and Kristine Nishida are co-first authors on ‘ Epithelial plasticity in COPD results in cellular unjamming due to an increase in polymerized actin’, published in JCS. Baishakhi is a post-doctoral fellow in the lab of Venkataramana K. Sidhaye at Johns Hopkins Bloomberg School of Public Health, Maryland, USA, evaluating the mechanisms by which inhaled pollutants can cause chronic injury to model chronic lung diseases. Kristine is a Research Associate in the FastForward Facility at Maryland, where she is interested in increasing the accessibility of cell and gene therapies to patients.

18 July 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
BGBaishakhi Ghosh
Baishakhi Ghosh
JLJeffrey Loube
Jeffrey Loube
STShreeti Thapa
Shreeti Thapa
ECErin Capodanno
Erin Capodanno
SMSaborny Mahmud
Saborny Mahmud
VSVenkataramana K. Sidhaye
Venkataramana K. Sidhaye
Chronic obstructive pulmonary disease (COPD) is a devastating lung disease, characterized by a progressive decline in lung function, alveolar loss (emphysema), and airflow limitation due to excessive mucus secretion (chronic bronchitis), that can occur even after the injurious agent is removed. It is slated to rise to the 3 rd leading cause of death due to chronic disease by 2030 globally, and the 4 th leading cause of death due to chronic disease in the USA. While there is substantial evidence indicating loss of E-cadherin in the lung epithelium of patients with COPD, it is not known if this is causal to the disease. We investigated if loss of E-cadherin can result in lung disease using in both in vitro models of primary, differentiated human cells and in mouse models. Using a cell type-specific promoter using Cre/LoxP mice system to knock-out E- cadherin in ciliated and alveolar epithelial cell (Type 1 and Type 2) populations in adult mouse models, we determined that loss of E-cadherin caused airspace enlargement, as well as increased airway hyperresponsiveness indicating that it does have a causative role in causing COPD. Strategies to upregulate CDH1 (encodes for E-cadherin) in CHBEs and cigarette-smoke injured NHBEs can rescue the dysfunctional epithelium.